Slides
Page 1
1 Q3 2026 SABIC EARNINGS CALL 25th October 2026
Page 2
2 Q3 2026 SABIC earnings call This presentation has been prepared solely for use at this meeting. By attending the meeting where this presentation is made or accessing this presentation, you agree to be bound by the following limitations. This material is given in conjunction with an oral presentation and should not be taken out of context. This presentation has been prepared for information and background purposes only. It does not constitute or form part of, and should not be construed as, an offer of, a solicitation of an offer to buy, or an invitation to subscribe for, underwrite or otherwise acquire, any securities of SABIC (the “Company”) any other existing or future member of the SABIC Group (the “Group”) or any other company including Saudi Aramco, nor should it or any part of it form the basis of, or be relied on in connection with, any contract to purchase or subscribe for any securities of any such company or with any other contract or commitment whatsoever. This presentation does not constitute a prospectus in whole or in part, and any decision to invest in securities should be made solely on the basis of the information to be contained in a prospectus and on an independent analysis of the information contained therein. Any assumptions, views or opinions (including statements, projections, forecasts or other forward-looking statements) contained in this presentation represent the assumptions, views or opinions of the Company as of the date indicated and are subject to change without notice. All information not separately sourced is from Company data and estimates. Information contained in this presentation related to past performance is not an indication of future performance. The information in this presentation is not intended to predict actual results, and no assurances are given with respect thereto. The information contained in this presentation has not been independently verified, and no representation or warranty, express or implied, is made as to the fairness, accuracy, completeness or correctness of the information contained herein, and no reliance should be placed on it. Neither the Company nor its affiliates, advisers, connected persons or any other person accepts any liability for any loss howsoever arising (in negligence or otherwise), directly or indirectly, from this presentation or its contents or otherwise arising in connection w ith this presentation. This shall not, however, restrict or exclude or limit any duty or liability to a person under any applicable law or regulation of any jurisdiction which may not lawfully be disclaimed (including in relation to fraudulent misrepresentation). This presentation includes “'forward-looking statements. ” These statements contain the words “anticipate, ” “believe, ” “intend, ” “estimate, ” “expect” and words of similar meaning. All statements other than statements of historical facts included in this presentation, including, without limitation, those regarding the Company’s financial position, business strategy, plans and objectives of management for future operations (including cost savings and productivity improvement plans) are forward-looking statements. By their nature, such forward-looking statements involve known and unknown risks, uncertainties and other important factors that could cause the actual results, performance or achievements of the Company to be materially different from results, performance or achievements expressed or implied by such forward-looking statements. Such forward-looking statements are based on numerous assumptions regarding the Company’s present and future business strategies and the market environment in which the Company will operate in the future. These forward-looking statements speak only as of the date of this presentation. Each of the Company, the relevant Group entities and their respective shareholders, agents, employees and advisers, expressly disclaims any obligation or undertaking to update any forward-looking statements contained herein. You are urged to consider these factors carefully in evaluating the forward- looking statements in this presentation and not to place undue reliance on such statements. This presentation is not directed to, or intended for distribution to or use by, any person or entity that is a citizen or re sident or located in any locality, state, country or other jurisdiction where such distribution, publication, availability or use would be contrary to law or regulation of such jurisdiction or which would require any registration or licensing within such jurisdiction. Any failure to comply with these restrictions may constitute a violation of the laws of other jurisdictions. The information contained in this presentation is provided as of the date of this presentation and is subject to change without notice. Note: with reference to ICIS in this presentation, ICIS has not seen or reviewed any conclusions, recommendations or other vi ews that may appear in this document. ICIS makes no warranties, express or implied, as to the accuracy, adequacy, timeliness, or completeness of its data or its fitness for any particular purpose. ICIS disclaims any and all liability relating to or arising out of use of its data and other content to the fullest extent permissible by law. DISCLAIMER
Page 3
3 Content 01 Macroeconomics & Microeconomics 02 Business Resilience 03 Highlights & Priorities 04 Financial Performance 05 Key Takeaways 06 Q&A
Page 4
4 Note: Data from 3rd Party Data Provider Global macroeconomic Global Growth Moderates Amid continued Manufacturing activity expansion Q3 2026 – SABIC’s Earnings Call Real GDP Growth (Year-on-Year change, %) Manufacturing PMI (Reference Index, #) 0% 2% 4% 6% Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26 Europe ChinaUnited StatesGlobal Asia • Global GDP growth stood at 2.3% in Q3 2026, with varying growth trends across major economies. • Interest rates edged higher at the end of Q3. • Global manufacturing PMI remained above 52, signaling continued expansion in manufacturing activity. 40 45 50 55 60 65 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26 06 05 04 03 02 01 01 Macro & Microeconomics
Page 5
5 Note: Data from 3rd Party Data Provider & Internal Intelligence Microeconomics Cost-advantaged Asset Positioning Supports Profitability & Competitiveness Through The Cycle Q3 2026 – SABIC’s Earnings Call • Industry operating rates remain near cyclical lows, with a gradual recovery expected as supply- demand conditions rebalance. • Advantaged feedstock mix positions key assets toward the lower end of the global cost curve. • Scale and global market access reinforce SABIC’s competitive position. Ethylene Balance & Operating Rates (Year-on-Year change, %) Global Cost Curve 70% 72% 74% 76% 78% 80% 82% 84% 86% 88% 90% 0 50 100 150 200 250 300 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 Demand Capacity Operating Rate Average Operating Rate (2010-2024) Production Cost Cumulative Production SABIC C2+SABIC C1 Quartile 1 Quartile 2 Quartile 3 Quartile 4 Lower Cost ← Higher Cost → 06 05 04 03 02 01 01 Macro & Microeconomics ↑↑
Page 6
6 Q3 2026 – SABIC’s Earnings Call Years of disciplined investments in robust business continuity planning, underpinned by financial strength reflected in our A+ credit rating, enabled SABIC to effectively navigate the crisis and mitigate its business impact ENABLED COORDINATED EXECUTION → Safety Sales & Operation Planning Agility Logistics Capabilities • Sustained EHSS Performance through challenging operating environment. • Optimized feedstock utilization leveraging ethylene network flexibility in Jubail. • 23% Increase in Polymers QoQ. • 24% Increase in Chemicals sales Volumes. QoQ. • 68% Increase in Agi- Nutrients sales Volumes QoQ. • First-ever urea shipment through NEOM Port. • 38% QoQ increase in vessel lifting. • 230% increase in Polymer volumes shuttled compared to pre-crisis levels. • Activated alternative shipping routes and logistic arrangements. SABIC Business Resilience Leveraging Integrated Capabilities to Sustain Business Continuity SABIC Assets SABIC Crisis Platforms Saudi Arabia Infrastructure Government Support SABIC Global Network Shareholder Support Resilience Enablers 06 05 04 03 02 Business Resilience 01
Page 7
7 1. Total Recordable incident rate 2. On EBITDA level & on Recurring basis, Excluding European Petrochemical Business and Engineering Thermoplastics Business in the Americas and Europe YTD. 3. a Saudi Aramco affiliate Quarterly Highlights – Q3 2026 Advancing Strategic Priorities Through Innovation, Portfolio Transformation And Accretive Growth Q3 2026 – SABIC’s Earnings Call Operational performance and innovation Portfolio and transformation Accretive growth • US$950 Mn realized2 YTD in transformation value, supporting structural cost and performance improvements. • Completed ETP Americas and Europe divestment, advancing portfolio optimization. • Key milestone toward establishing a national petrochemicals logistics champion. • 0.06 TRIR1, reflecting strong EHSS performance. • R&D 100 Award received for a first- of-its-kind technology for solar PV manufacturing. • Advancing localization and domestic demand through NUSANED . • Progressing the Fujian Petrochemical Complex, with 3 core units completing successful trial runs. • 54% planned increase in urea production capacity, following FID. • 1.8 MMT of methanol production capacity enabled following feedstock allocation. • 1.2 MMT of PE marketing agreement through deeper commercial integration with S-Oil3. 06 05 04 03 Highlights & Priorities 02 01
Page 8
8 Focused Execution strengthening SABIC’s resilience and positioning the portfolio for value creation. Executing With Discipline Across Our Strategic Priorities Q3 2026 – SABIC’s Earnings Call 1. On EBITDA level & on Recurring basis. 2. Capital expenditure (“CAPEX”) and capital injection for SABIC’s growth project, including CAPEX expensed off in the discontinued businesses. 06 05 04 03 Highlights & Priorities 02 01 Portfolio Optimization continued focus to uplift ROCE Transformation delivery of US$ 3.00 Bn1 target by 2030 Capital discipline Capital investment2 of US$ 3.0 – 3.3 Bn Selective growth SABIC Fujian complex in China, Urea & Methanol growth
Page 9
9 Financial Performance – Continuing Operations Resilient Financial Performance Despite On-going Uncertainties Q3 2026 – SABIC’s Earnings Call US$ 7.51 Bn. REVENUE 30% Higher Sales Volumes QoQ 14% ↑ (Compared with Q2 2026) Q2 2026 Adjusted EBITDA of US$ 0.90 Bn Q2 2026 Adjusted EBITDA margin of 14% US$ 1.27 Bn. ADJUSTED1 EBITDA2 17 % ADJUSTED1 EBITDA2 MARGIN 40% ↑ (Compared with Q2 2026) 323 bps ↑ (Compared with Q2 2026) US$ 327 Mn.↑ (Compared with Q2 2026) 2% ↑ (Compared with YTD 2025) Reported Net Income3 of US$ 676 Mn Compared with US$ 1.0 Bn in 2025 Robust Financial Standing US$ 225 Mn. ADJUSTED1 NET INCOME3 US$ 1.1 Bn. Free Cash Flow4 (YTD) US$ 0.81 Bn. NET DEBT 5 In this and all the subsequent slides: USD/SAR Rate: 3.75; Certain figures and percentages have been subject to rounding adjustments. 1 Reflects SABIC's underlying operational performance based on normal course of business by eliminating the effects of non-operational anomalies and one-offs & discontinued operations. 2 EBITDA = Income from operations plus depreciation, amortization and impairment. 3 Net Income - Attributable to equity holders to the parent. 4. Total company including discontinued operations, Free Cash Flow = net cash from operating activities minus capital expenditure. Capital expenditure = Purchase of tangibles and intangibles, net.. 5. Short term borrowings + debt + lease liabilities - cash and cash equivalents - short-term investments. 06 0504 Financial Performance 03 02 01
Page 10
10 1. Reflects SABIC's underlying operational performance based on normal course of business by eliminating the effects of non-operational anomalies and one-offs & Discontinued operations. 2. EBITDA = Income from operations plus depreciation, amortization and impairment. 3. Compared with 2025 YTD. 4. On EBITDA level & on Recurring basis, Excluding European Petrochemical Business and Engineering Thermoplastics Business in the Americas and Europe. 5. Mainly results of integral JVs, FX Impact & others Transformation Realization • Higher sales volumes by 30% and lower prices by 13% • Margins improved despite lower sales prices & higher logistic costs. • Reduced G&A by 5% YTD3, reflecting continued cost discipline and efficiency. • Delivered US$ 950 Mn4 in Transformation YTD. Adjusted1 EBITDA2 (US$ Bn) Q3 2026 – SABIC’s Earnings Call Quarterly EBITDA Performance Profitability expansion reflects operational normalization and continued cost discipline 06 0504 Financial Performance 03 02 01 Adjusted EBITDA margin 13.64% 16.87% 1.4 0.9 1.3 Q3 25 Q2 26 Volumes Margins Others Q3 26 5
Page 11
11 1. 2024 rebased to 100 2. Including FX & other factors 3. Reflects SABIC's underlying operational performance based on normal course of business by eliminating the effects of non-operational anomalies and one-offs & discontinued operations Sales Drivers Volumes Prices2 Q3 26 vs Q2 26 24% ↑ 10%↓ Polymers Chemicals Sales volumes • Total Petrochemicals sales volume increased to 6.71 MMT during Q3 2026 • Prices eased from Q2 highs, as buyers remain cautious amid persistent uncertainties. 0 50 100 150 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 631 1,041 Q2 2026 Q3 2026 Petrochemicals Price Index1 Petrochemicals Adjusted3 EBITDA (US$ Mn) Q3 2026 – SABIC’s Earnings Call Financial Performance – Petrochemicals Resilient Financial Performance Despite On-going Uncertainties 06 0504 Financial Performance 03 02 01
Page 12
12 • Total Agri-Nutrients sales volume increased to 1.62 MMT during Q3 2026 • Prices moderated from Q2 highs, with demand weakness contributing to price volatility amid ongoing uncertainties. Agri-Nutrients Price Index1 Q3 2026 – SABIC’s Earnings Call 60 90 120 150 180 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Urea Ammonia Phosphate Sales volumes Sales Drivers Volumes Prices2 Q3 26 vs Q2 26 68% ↑ 20% ↓ 181 160 Q2 2026 Q3 2026 Financial Performance – Agri-Nutrients Resilient Financial Performance Despite On-going Uncertainties 06 0504 Financial Performance 03 02 01 1. 2024 rebased to 100 2. Including FX & other factors 3. Reflects SABIC's underlying operational performance based on normal course of business by eliminating the effects of non-operational anomalies and one-offs & discontinued operations Agri-Nutrients Adjusted3 EBITDA (US$ Mn)
Page 13
13 1. 2024 rebased to 100 2. Including FX & other factors 3. Reflects SABIC's underlying operational performance based on normal course of business by eliminating the effects of non-operational anomalies and one-offs & discontinued operations • Total Specialties sales volume of 65 KMT during Q3 2026 • Demand from AI Infrastructure growth continues with higher average selling prices in Q3 driven by a favorable product mix. Specialties Price Index1 Q3 2026 – SABIC’s Earnings Call Sales Drivers Volumes Prices2 Q3 26 vs Q2 26 0% 3% ↑ Sales volumes Electronics Medical Devices Industrial Infrastructure Mobility 80 110 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 101 124 Q2 2026 Q3 2026 Financial Performance – Specialties Continued Resilient Financial Performance 06 0504 Financial Performance 03 02 01 Specialties Adjusted3 EBITDA (US$ Mn)
Page 14
14 1. YTD on EBITDA level & on recurring basis, Excluding European Petrochemical Business (EP) and Engineering Thermoplastics Business (ETP) in the Americas and Europe 2. Aggregate cash proceeds from completed portfolio optimization actions (2024 -2026) YTD 3. Average annual loss from operations (2024-2025) attributable to sold assets (EP & ETP west). Building a more focused, competitive, and resilient SABIC Addressing structural industry challenges through transformation, portfolio optimization and selective growth Q3 2026 – SABIC’s Earnings Call Industry Environment • Overcapacity and supply-demand imbalances • Continued pressure on margins • Geopolitical uncertainty SABIC Actions Transform1 Outlook Optimize Grow US$ 950 Mn Advancing structural cost and performance improvements. US$ 2.3 Bn Actions taken: • Hadeed exit • Alba exit • Functional forms exit • ETP & EP Divestments Advantaged Regions & Value Chains • SABIC Fujian → Start-up progress • Urea Expansion → FID reached • Methanol Expansion → Gas allocated Operational Resilience Strengthen safety and reliability. Transformation Drive efficiency and competitiveness. Disciplined Growth Invest selectively to enhance shareholder value. Cash Proceeds Generated2 Annual losses avoided3 US$ 1.4 Bn 06 05 Key Takeaways 04 03 02 01
Page 15
15 15 Questions & Answers 06 Q&A 05 04 03 02 01
Page 16
16 Continuous Dialogue With The Investment Community FIND MORE INFORMATION ON: www.sabic.com /en/investors IR@SABIC.com Investors Continuous dialogue Q3 2026 – SABIC’s Earnings Call 06 Investor Relations 05 04 03 02 01
Page 17
17 Thank You
Page 18
18 Financial Performance Financial Performance Q3 2026 – SABIC’s Earnings Call Key Ratios Q3 26 Q2 26 Q3 25 YTD 26 YTD 25 Adjusted1 EBITDA2 margin (%) 16.9 13.6 17.5 15.5 16.4 Net debt /Adjusted1 EBITDA2 (x) 0.16 0.2 (0.03) 0.18 (0.03) (US$ Bn. ) Q3 26 Q2 26 Q3 25 YTD 26 YTD 25 Revenue 7.51 6.62 7.75 21.10 23.62 EBITDA2 1.26 1.01 1.35 3.38 3.57 Adjusted1 EBITDA2 1.27 0.9 1.36 3.28 3.89 Income from operations (EBIT) 0.55 0.19 0.61 1.13 1.40 Adjusted1 income from operations (EBIT) 0.58 0.11 0.62 1.07 1.73 Net Income3 continuing operations 0.68 -0.02 0.40 0.87 0.49 Net Income3 discontinuing operations -0.54 -0.2 -0.28 -0.96 -1.78 Net income3 (Total) 0.13 -0.22 0.12 -0.09 -1.29 Adjusted1 net income3 0.23 -0.10 0.36 0.34 0.92 Free cash flow4 1.50 -0.37 1.16 1.05 1.03 Sales Drivers Volume Prices5 Q3 26 vs. Q2 26 30% ↑ 13% ↓ Q3 26 vs. Q3 25 22% ↓ 24% ↑ YTD 26 vs. YTD 25 24% ↓ 21% ↑ 1 Reflects SABIC's underlying operational performance based on normal course of business by eliminating the effects of non-operational anomalies, one-offs and discontinuing operations. 2 EBITDA = Income from operations plus depreciation, amortization and impairment. 3 Net Income - Attributable to equity holders to the parent.. 4 Free Cash Flow = net cash from operating activities minus capital expenditure. Capital expenditure = Purchase of tangibles and intangibles, net. 5 Includes FX & other factors.